...
首页> 外文期刊>Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism >Treatment of secondary brain injury by perturbing postsynaptic density protein-95-NMDA receptor interaction after intracerebral hemorrhage in rats
【24h】

Treatment of secondary brain injury by perturbing postsynaptic density protein-95-NMDA receptor interaction after intracerebral hemorrhage in rats

机译:大鼠脑内出血后扰动突触后密度蛋白-95-NMDA受体相互作用的继发性脑损伤治疗

获取原文
获取原文并翻译 | 示例

摘要

Postsynaptic density protein-95 (PSD95) plays important roles in the formation, differentiation, remodeling, and maturation of neuronal synapses. This study is to estimate the potential role of PSD95 in cognitive dysfunction and synaptic injury following intracerebral hemorrhage (ICH). The interaction between PSD95 and NMDA receptor subunit NR2B-neurotransmitter nitric oxide synthase (nNOS) could form a signal protein complex mediating excitatory signaling. Besides NR2B-nNOS, PSD95 also can bind to neurexin-1-neuroligin-1 to form a complex and participates in maintaining synaptic function. In this study, we found that there were an increase in the formation of PSD95-NR2B-nNOS complex and a decrease in the formation of neurexin-1-neuroligin-1-PSD95 complex after ICH, and this was accompanied by increased neuronal death and degeneration, and behavior dysfunction. PSD95 inhibitor Tat-NR2B9c effectively inhibited the interaction between PSD95 and NR2B-nNOS, and promoted the formation of neurexin-1-nueuroligin-1-PSD95 complex. In addition, Tat-NR2B9c treatment significantly reduced neuronal death and degeneration and matrix metalloproteinase 9 activity, alleviated inflammatory response and neurobehavioral disorders, and improved the cognitive and learning ability of ICH rats. Inhibition of the formation of PSD95-NR2B-nNOS complex can rescue secondary brain injury and behavioral cognitive impairment after ICH. PSD95 is expected to be a target for improving the prognosis of patients with ICH.
机译:突触后密度蛋白-95(PSD95)在神经元突触的形成,分化,重塑和成熟中起重要作用。本研究是估计PSD95在脑出血(ICH)后认知功能障碍和突触损伤的潜在作用。 PSD95和NMDA受体亚基NR2B-神经递质一氧化氮合酶(NNOS)之间的相互作用可以形成介导兴奋性信号的信号蛋白质复合物。除了NR2B-NNOS,PSD95还可以与Neurexin-1-NeuroLigin-1结合形成复合物并参与保持突触功能。在这项研究中,我们发现PSD95-NR2B-NNOS复合物的形成增加,并且在ICH之后的Neurexin-1-neuroligin-1-PSD95复合物的形成减少,这伴随着神经元死亡增加和退化和行为功能障碍。 PSD95抑制剂TAT-NR2B9C有效地抑制了PSD95和NR2B-NNO之间的相互作用,并促进了Neurexin-1-Nuuuroligin-1-PSD95复合物的形成。此外,TAT-NR2B9C治疗显着降低了神经元死亡和变性和基质金属蛋白酶9活性,缓解炎症反应和神经表现障碍,并改善了ICH大鼠的认知和学习能力。抑制PSD95-NR2B-NNOS复合物的形成可以在ICH后抢救继发性脑损伤和行为认知障碍。 PSD95预计是改善ICH患者预后的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号